Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-25 Sale | 2024-10-25 7:28 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $80.89 | $889,790 | 11,000 (Direct) | View |
2024-02-08 Sale | 2024-02-08 7:38 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $28.05 | $701,250 | 0 (Direct) | View |
2024-01-19 Sale | 2024-01-19 8:35 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $23.05 | $691,500 | 25,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-25 Exercise | 2024-10-25 7:28 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $0 | 11,000 (Direct) | View |
2024-10-25 Exercise | 2024-10-25 7:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $4.88 | 11,000 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:38 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $8.32 | 0 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:38 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $0 | 0 (Direct) | View |
2024-01-19 Exercise | 2024-01-19 8:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $8.32 | 25,000 (Direct) | View |
2024-01-19 Exercise | 2024-01-19 8:35 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $0 | 25,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 9:25 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 32,000 | $0 | 32,000 (Direct) | View |
2023-01-03 Option Award | 2023-01-04 6:11 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $0 | 22,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:10 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $0 | 22,000 (Direct) | View |
2021-06-30 Option Award | 2021-07-07 5:46 pm | N/A N/A | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rouan Sarah Kathryn Director | 4,892 | $0 | 18,242 (Direct) | View |
2021-01-13 Option Award | 2021-01-14 4:38 pm | 2022-01-13 2031-01-13 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rouan Sarah Kathryn Director | 2,500 | $0.001 | 15,850 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 4:38 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $0 | 22,000 (Direct) | View |
2020-02-06 Option Award | 2020-02-07 4:13 pm | 2021-02-06 2030-02-06 | NAVIDEA BIOPHARMACEUTICALS INC. | NAVB | Rouan Sarah Kathryn Director | 2,500 | $0.001 | 18,350 (Direct) | View |
2020-01-02 Option Award | 2020-01-03 7:54 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $0 | 22,000 (Direct) | View |